Purchase Order 75N91020P00507

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $28,202.00 on June 21, 2018, for the purchase of a SpectraMax Plus 384 plate reader. Place of performance is Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of July 13, 2018. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for a microplate reader on September 22, 2020, with a ceiling value of $24,987.78 and a firm fixed price. Work is performed in San Jose, California, with an ultimate completion date of October 30, 2020. No small business set-aside applies to this order.</p>

<p>The Food and Drug Administration awarded a purchase order to Molecular Devices LLC for a SpectraMax ABS single-mode microplate reader valued at $15,794.00, with an award date of August 23, 2022 and ultimate completion date of September 22, 2022. Place of performance is San Jose, California. The order is firm fixed price with no set-aside applied.</p>

The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $14,555 purchase order to Molecular Devices LLC for a service agreement for the SpectroMax i3x plate reader. The contract has a period of performance from December 15, 2023 through December 14, 2024 and utilizes a firm fixed price pricing structure. Molecular Devices LLC will provide plate reader services from its Rockville, Maryland location to support the National Cancer Institute's...

<p>The National Cancer Institute awarded a purchase order to Government Scientific Source Inc., a small business, for a SpectraMax ID3 microplate reader on August 19, 2019, with a ceiling value of $24,962.00 and an ultimate completion date of September 19, 2019. Place of performance is Reston, Virginia. The order carries firm fixed price terms and no set-aside designation.</p>

The National Cancer Institute awarded a purchase order to Stripes Global, Inc., a service-disabled veteran-owned small business and SBA 8(a) program participant, for a Molecular Devices SpectraMax ID3 microplate reader system on August 27, 2018, with a ceiling value of $24,557. The order carries a total small business set-aside designation. Performance is located in Bethesda, Maryland, with an ultimate completion date of October 8, 2018. The solicitation was posted August 9, 2018, with a due...

<p>The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $24,065.00 on June 28, 2018, with ultimate completion June 28, 2019. No set-aside applies. Place of performance is San Jose, California. The order is firm fixed price for laboratory instruments or related equipment and services, consistent with Molecular Devices' core offerings in bioanalytical instrumentation, imaging systems, and associated maintenance.</p>

The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $12,249.00 on August 28, 2018, for a one-year service contract covering I3X Plate Reader maintenance and support from September 1, 2018, to August 31, 2019. Performance takes place in San Jose, California. Molecular Devices, a subsidiary of Danaher Corporation, manufactures advanced bioanalytical laboratory instruments and provides associated maintenance and software support to federal research agencies on a...

The National Cancer Institute awarded a purchase order to Government Scientific Source Inc., a for-profit small business, on September 26, 2018, with a ceiling value of $48,530.00 for procurement of a SpectraMax ID5 multi-mode microplate reader (brand name or equal) for adoptive cell therapy screening in support of clinical trial patients. Work is performed in Reston, Virginia. The order carries firm fixed pricing and an ultimate completion date of October 25, 2018. No set-aside was applied.

The National Cancer Institute awarded a purchase order to Molecular Devices LLC for $23,525.00 on August 20, 2019, for scientific equipment, with performance scheduled through September 30, 2019. Work is performed in San Jose, California. Molecular Devices, a subsidiary of Danaher Corporation, manufactures bioanalytical laboratory instruments including microplate readers, high-content imaging systems, and electrophysiology equipment sold to federal research agencies on a full-and-open,...